Clause 25 Relationships with Health Professionals, Other Relevant Decision Makers, Healthcare Organisations and Patient Organisations

Clause 25
;

25.1

(27.4) No company may require that it be the sole funder or sponsor of a healthcare organisation or patient organisation or any of its programmes.

25.2

(27.5) A company must not make public use of a healthcare organisation or patient organisation’s logo and/or proprietary material without the organisation’s written agreement. In seeking such permission, the specific purpose and the way in which the logo and/or proprietary material will be used must be clearly stated.

25.3

(27.9) Companies must ensure that all sponsorship is clearly acknowledged from the outset. The wording of the declaration of sponsorship must be unambiguous and accurately reflect the extent of the company’s involvement and influence over the material.

most recent cases See all Applicable Code year
Applicable Code year

Please check the date of the Code that applies to the Case that you are looking at. The date of the complaint may vary from the activity/material alleged to have been in breach.

AUTH/3898/5/24 - Complainant v GSK Breach: 25.3 No breach: 2, 5.1, 8.1, 8.3, 25.3 Applicable Code: 2021 Received: 08 May 2024 Completed: 08 August 2025 AUTH/3921/06/24 - Complainant v Jazz Pharmaceuticals UK Breach: 5.1, 23.2, 25.3 No breach: 2, 5.1 Applicable Code: 2021 Received: 07 June 2024 Completed: 09 July 2025 AUTH/3897/5/24 - Complainant v Roche Breach: 25.3 No breach: 2, 5.1, 8.3 Applicable Code: 2021 Received: 06 May 2024 Completed: 08 July 2025 CASE/0219/06/24 - Complainant v Organon Breach: 23.2, 25.3 No breach: 2, 5.1 Received: 26 June 2024 Completed: 01 July 2025 AUTH/3895/5/24 - Complainant v GSK Breach: 25.3 No breach: 2, 5.1, 8.3 Applicable Code: 2021 Received: 04 May 2024 Completed: 30 June 2025 AUTH/3907/05/24 - Complainant v Jazz Pharmaceuticals UK Breach: 23.2, 25.3 No breach: 2, 5.1 Applicable Code: 2021 Received: 16 May 2024 Completed: 20 June 2025 AUTH/3914/05/24 - Complainant v Jazz Pharmaceuticals Breach: 25.3 No breach: 2, 5.1, 23.2 Applicable Code: 2021 Received: 31 May 2024 Completed: 13 June 2025 AUTH/3845/11/23 - Complainant v GSK Breach: 25.3 No breach: 2, 5.1, 27.2 Applicable Code: 2021 Received: 02 November 2023 Completed: 13 March 2025 AUTH/3676/7/22 - Complainant v Roche Breach: 23.2, 25.3 No breach: 2, 5.1, 6.5, 12.1, 26.1, 26.2 Applicable Code: 2021 Received: 07 July 2022 Completed: 28 February 2024 CASE/0274/08/24 - Complainant v Organon No breach: 2, 5.1, 10.9, 25.3 Applicable Code: 2021 Received: 18 August 2024 Completed: 05 August 2025 AUTH/3893/4/24 - Complainant/Chief Executive v Roche No breach: 2, 3.3, 5.1, 25.3 Applicable Code: 2021 Received: 29 April 2024 Completed: 11 June 2025 AUTH/3896/5/24 - Complainant v Roche No breach: 2, 5.1, 23.2, 25.3 Applicable Code: 2021 Received: 07 May 2024 Completed: 25 April 2025

25.4

(12.2) Market research activities, clinical assessments, post-marketing surveillance and experience programmes, post-authorisation studies (including those that are retrospective in nature), and the like must not be disguised promotion. They must be conducted with a primarily scientific or educational purpose.

most recent cases See all Applicable Code year
Applicable Code year

Please check the date of the Code that applies to the Case that you are looking at. The date of the complaint may vary from the activity/material alleged to have been in breach.